agilon health (NYSE:AGL) Given New $2.00 Price Target at Stifel Nicolaus

agilon health (NYSE:AGL) had its price target decreased by Stifel Nicolaus from $7.00 to $2.00 in a report issued on Tuesday,Benzinga reports. Stifel Nicolaus currently has a hold rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Deutsche Bank Aktiengesellschaft decreased their target price on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research report on Friday, August 9th. Evercore ISI cut their price target on shares of agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Royal Bank of Canada restated an “outperform” rating and issued a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. TD Cowen dropped their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, William Blair lowered shares of agilon health from an “outperform” rating to a “market perform” rating in a research note on Friday, November 8th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat, agilon health presently has a consensus rating of “Hold” and a consensus price target of $6.38.

agilon health Price Performance

AGL opened at $1.59 on Tuesday. The company’s 50 day simple moving average is $3.05 and its 200 day simple moving average is $4.86. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 1 year low of $1.58 and a 1 year high of $13.76. The stock has a market capitalization of $653.05 million, a PE ratio of -1.69 and a beta of 0.60.

agilon health (NYSE:AGL) last released its earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.19). agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. During the same period in the prior year, the business posted ($0.06) earnings per share. As a group, sell-side analysts expect that agilon health will post -0.43 EPS for the current year.

Insider Activity

In related news, CEO Steven Sell acquired 20,000 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were acquired at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now directly owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its position in agilon health by 1.3% in the first quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares in the last quarter. Capital International Investors raised its position in agilon health by 84.7% in the first quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. State Street Corp raised its position in agilon health by 3.0% in the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock worth $29,277,000 after acquiring an additional 215,733 shares in the last quarter. Citigroup Inc. raised its position in agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock worth $7,971,000 after acquiring an additional 1,941,993 shares in the last quarter. Finally, AQR Capital Management LLC raised its position in agilon health by 3,338.5% in the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company’s stock worth $8,871,000 after acquiring an additional 1,316,990 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.